dr. wakelee on detection of egfr t790m mutation in nsclc
Published 7 years ago • 397 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
1:57
dr. wakelee on benefits of osimertinib in egfr-mutant nsclc treatment
-
1:29
dr. wakelee on available treatments following tumor progression in lung cancer
-
1:16
dr. wakelee on first-line therapy for egfr-mutant lung cancer
-
1:05
dr. wakelee on recent advancements in egfr-mutant nsclc
-
1:27
dr. wakelee discusses egfr tkis in lung cancer
-
1:00
dr. husain on the future of monitoring t790m in lung cancer
-
2:03
dr. wakelee on rationale to explore osimertinib with concurrent chemotherapy in egfr-mutant nsclc
-
3:59
osimertinib for egfr t790m resistance mutations in nsclc
-
1:41
dr. husain on monitoring the emergence of t790m in lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:36
dr. heather wakelee on what to do when resistance to egfr tkis emerges
-
1:21
dr. wakelee on importance of ngs testing in nsclc
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:32
dr. wakelee on immunotherapy versus targeted agents in nsclc
-
1:35
dr. wakelee on unmet needs for immunotherapy in nsclc
-
3:45
azd9291 and rociletinib in t790m-mutant nsclc
-
1:13
dr. wakelee discusses the future of lung cancer adjuvant therapy
-
8:29
liquid vs. tissue biopsies to detect t790m mutations
-
2:42
use of liquid biopsies for patients with egfr-mutated non–small cell lung cancer